Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVDX, TASK, BRDG on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers AVDX BRDG TASK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BSGM, SGN, HLGN on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers BSGM HLGN SGN
PFM CRYPTO Launches New 2-Day XRP Cloud Mining Contract in Response to The Surge in Demand from Short-Term Income Investors
From PFM CRYPTO
Via GlobeNewswire
Afognak Native Corporation Hires New CEO
From Afognak Native Corporation
Via GlobeNewswire
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
From Gatorade
Via GlobeNewswire
Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
From Arvinas Inc.
Via GlobeNewswire
Tickers ARVN PFE
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
From https://immatics.com/
Via GlobeNewswire
Tickers IMTX
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
From Ipsen Pharma
Via GlobeNewswire
Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge
From Network for Teaching Entrepreneurship (NFTE)
Via GlobeNewswire
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
From Xilio Therapeutics, Inc.
Via GlobeNewswire
Tickers XLO
Investors Mobilize to ‘Free Linqto’ Amid Concerns of Mismanagement
From Free Linqto
Via GlobeNewswire
Bragar Eagel & Squire, P.C. is Investigating CaaStle, Inc. on Behalf of Stockholders and Encourages Fund Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Tickers TEVA
TRAXXAS ALERT: Bragar Eagel & Squire, P.C. is Investigating Traxxas, L.P. on Behalf of Traxxas Customers and Encourages Consumers to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Tickers TEVA
ORGANON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organon & Co. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers OGN
ICHOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Ichor Holdings, Ltd. on Behalf of Ichor Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ICHR
Data Speaks Officially Launches to Redefine Marketing Measurement for the Digital Era
From Data Speaks
Via GlobeNewswire
Hydreight Reports 34% Year-Over-Year Q1 Revenue Growth, Improvement in Bottom Line Results, and Delivers Strong Performance Across Verticals
From Hydreight Technologies Inc.
Via GlobeNewswire
Tickers HYDTF TSX-V:NURS
Digi Power X Establishes US$100 Million at-the-Market Equity Program to Accelerate Growth
From Digi Power X Inc.
Via GlobeNewswire
Tickers DGHI DGXX TSX-V:DGHI TSX-V:DGX
Associa Recognized as a US Best Managed Company
From Associa
Via GlobeNewswire
Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting
From Perspective Therapeutics, Inc.
Via GlobeNewswire
Stantec Announces Private Offering of $425 Million Senior Unsecured Notes
From Stantec
Via GlobeNewswire
Tickers STN TSX:STN
Highrock Resources Options Ontario Gold Property
From Highrock Resources Ltd.
Via GlobeNewswire
Tickers CSE:HRK
Oak Woods Acquisition Corporation Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
From OAK WOODS ACQUISITION CORP
Via GlobeNewswire
Tickers OAKU
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
Tickers MEDIF TSX:LABS
ContextLogic Inc. to Commence Trading on the OTC Markets and Delist from Nasdaq
From ContextLogic Inc.
Via GlobeNewswire
Tickers LOGC
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
From Fate Therapeutics, Inc.
Via GlobeNewswire
Tickers FATE NBIX
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.